National Planning Corporation’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-28,746
Closed -$732K 1276
2014
Q4
$732K Buy
28,746
+18,033
+168% +$433K 0.05% 307
2014
Q3
$237K Buy
10,713
+202
+2% +$4.39K 0.02% 620
2014
Q2
$218K Buy
10,511
+189
+2% +$3.97K 0.02% 660
2014
Q1
$231K Sell
10,322
-65
-0.6% -$1.45K 0.02% 607
2013
Q4
$215K Sell
10,387
-19,912
-66% -$386K 0.02% 611
2013
Q3
$596K Buy
+30,299
New +$580K 0.06% 315

Other funds holding HQL

National Planning Corporation's HQL Position: Q1 2015 in Review

National Planning Corporation sold out of abrdn Life Sciences Investors (HQL) in Q1 2015, closing a stake of 28,746 shares — an estimated $732K sold.

National Planning Corporation first reported a position in HQL in Q3 2013 and held it in 6 quarters. The position peaked at $732K in Q4 2014. 45 funds tracked by Wall St. Rank hold HQL as of Q1 2015.

  • National Planning Corporation reported no remaining abrdn Life Sciences Investors position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 28,746 abrdn Life Sciences Investors shares in Q1 2015, an estimated $732K.
  • National Planning Corporation first reported a position in abrdn Life Sciences Investors in Q3 2013 and held it in 6 quarters.
  • National Planning Corporation's abrdn Life Sciences Investors position peaked at $732K in Q4 2014.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.